Profil bibliographique

Maggie Czarnogorski

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

41Publications signalées

578Citations signalées

1Affiliations récentes

Institutions déclarées

ViiV Healthcare (Spain)

Domaines associés

HIV/AIDS Research and InterventionsHIV/AIDS drug development and treatmentHIV, Drug Use, Sexual RiskHIV Research and TreatmentHIV-related health complications and treatments

Publications récentes

Accès ouvert 2026 articleOpenAlex

Implementation Journey with CAB LA for PrEP Among Men Who Have Sex with Men and Transgender Men: Insights from the PILLAR Trial Through 12 Months

Nanlesta Pilgrim, Hadrian Holder, Julian A. Torres, Roberto Ortiz et autres

0 citationsAIDS and Behavior

Accès ouvert 2026 articleOpenAlex

P-313. Black Women’s Experiences on Long-Acting Cabotegravir for PrEP: Interim Patient Findings from the EBONI Study

Katherine Nelson, Zandraetta Tims-Cook, Helena Kwakwa, Megan Dieterich et autres

1 citationOpen Forum Infectious Diseases

Accès ouvert 2026 articleOpenAlex

Feasibility, Fidelity, and Effectiveness of Administering Long-Acting Cabotegravir + Rilpivirine in Infusion Centers in the United States: Findings From the Phase 4 GLACIER Implementation Study

Cassidy A. Gutner, Conn Harrington, Gilda Bontempo, Sivakumar Pazhamalai et autres

0 citationsJournal of the International Association of Providers of AIDS Care (JIAPAC)

Accès ouvert 2025 articleOpenAlex

Early experiences with usage of long‐acting injectable cabotegravir among adults in rural Ugandan and Kenyan communities: qualitative research from the SEARCH “Dynamic Choice HIV Prevention” intervention trials

Carol S. Camlin, Anjeline Onyango, Jason Johnson‐Peretz, Cecilia Akatukwasa et autres

1 citationJournal of the International AIDS Society

Accès ouvert 2025 articleOpenAlex

Feasibility and acceptability of persons on long‐acting cabotegravir for HIV prevention in the SEARCH Dynamic Choice HIV Prevention trial extension in rural Kenya and Uganda: a longitudinal cohort study

Elijah Kakande, Laura B. Balzer, Jane Kabami, James Ayieko et autres

3 citationsJournal of the International AIDS Society

Accès ouvert 2025 articleOpenAlex

Strategies for implementing long‐acting cabotegravir for PrEP in US clinics serving Black women: interim healthcare provider findings from the EBONI study

Katherine Nelson, Yolanda Lawson, Dylan Baker, Satish Mocherla et autres

5 citationsJournal of the International AIDS Society

Accès ouvert 2025 articleOpenAlex

P-1879. Change in Healthcare Professional’s Identification, Counseling, and Adherence with Black Women for Long-Acting Cabotegravir (CAB LA) for PrEP Across Women’s Health, Primary Care, and Infectious Diseases Sites: Findings from the EBONI Study

Katherine Nelson, Satish Mocherla, Yolanda Lawson, Alftan Dyson et autres

0 citationsOpen Forum Infectious Diseases

Accès ouvert 2025 articleOpenAlex

P-1424. Patient Experiences at Month 6 after Initiation of Cabotegravir Long-Acting (CAB LA) for PrEP in the First Male Gender Concordant Implementation Science Trial (PILLAR) in the US

Hadrian Holder, Nanlesta Pilgrim, Roberto Ortiz, William M. Valenti et autres

2 citationsOpen Forum Infectious Diseases

Accès ouvert 2025 articleOpenAlex

P-1899. Improvement in Provider Experiences from Baseline to Month 12 with Integrating Cabotegravir Long-Acting (CAB LA) for PrEP into Care in an Implementation Science Trial (PILLAR)

Taimur Khan, Jonathan M. L. White, Leida Mercado, Bo Li et autres

0 citationsOpen Forum Infectious Diseases

Accès ouvert 2025 articleOpenAlex

P-545. Feasibility, Fidelity, and Effectiveness of Administering CABENUVA in Infusion Centers

Cassidy A. Gutner, Conn Harrington, Gilda Bontempo, Sivakumar Pazhamalai et autres

2 citationsOpen Forum Infectious Diseases

Accès ouvert 2024 articleOpenAlex

Implementation of long‐acting cabotegravir and rilpivirine: primary results from the perspective of staff study participants in the Cabotegravir And Rilpivirine Implementation Study in European Locations

Cassidy A. Gutner, Laurent Hocqueloux, Celia Jonsson‐Oldenbüttel, Linos Vandekerckhove et autres

12 citationsJournal of the International AIDS Society

Accès ouvert 2024 articleOpenAlex

Safety and Effectiveness From the Cabotegravir and Rilpivirine Implementation Study in European Locations Study: Phase 3b Hybrid Type III Implementation Study Integrating Cabotegravir + Rilpivirine Long-Acting Into European Clinical Settings

Celia Jonsson‐Oldenbüttel, Jade Ghosn, Marc van der Valk, Éric Florence et autres

18 citationsJAIDS Journal of Acquired Immune Deficiency Syndromes

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.